These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 5056428)

  • 1. RNA methylation, a possible genetic marker in cystic fibrosis.
    Rennert OM; Julius RL; LaPointe D
    Pediatrics; 1972 Sep; 50(3):485-7. PubMed ID: 5056428
    [No Abstract]   [Full Text] [Related]  

  • 2. RNA methylation and polyamine metabolism in cystic fibrosis.
    Rennert OM
    Minerva Pediatr; 1976 Jan; 28(2):62-8. PubMed ID: 943684
    [No Abstract]   [Full Text] [Related]  

  • 3. An evaluation of differential methylation of ribonucleic acid in cystic fibrosis.
    Hodes ME; Merritt AD; Glier JT
    Pediatr Res; 1974 Mar; 8(3):212-4. PubMed ID: 4815835
    [No Abstract]   [Full Text] [Related]  

  • 4. The detection of the heterozygote and homozygote in cystic fibrosis by short term lymphocyte culture studies: a defect in RNA methylation.
    Rennert OM; Frias JL; Julius RL; Lapointe D
    Clin Pediatr (Phila); 1972 Jun; 11(6):351-2. PubMed ID: 5032161
    [No Abstract]   [Full Text] [Related]  

  • 5. Operational definition of cystic fibrosis. I.
    Hösli P; Kollberg H; Vogt E
    Monogr Paediatr; 1979; 10():90-5. PubMed ID: 460285
    [No Abstract]   [Full Text] [Related]  

  • 6. Cystic fibrosis. In vitro and in vivo studies on the biochemical background to the pathogenesis.
    Ceder O
    Acta Paediatr Scand Suppl; 1983; 309():1-47. PubMed ID: 6581681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic fibrosis: growth kinetics and production of the ciliary inhibitor by cultured fibroblasts.
    Barnett DR; Barranco SC; Lockhart LH; Lankford BJ; Meyne J; Bowman BH
    Tex Rep Biol Med; 1973; 31(4):691-6. PubMed ID: 4787662
    [No Abstract]   [Full Text] [Related]  

  • 8. Four novel cystic fibrosis mutations in splice junction sequences affecting the CFTR nucleotide binding folds.
    Dörk T; Wulbrand U; Tümmler B
    Genomics; 1993 Mar; 15(3):688-91. PubMed ID: 7682196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sweat chloride concentrations in infants homozygous or heterozygous for F508 cystic fibrosis.
    Farrell PM; Koscik RE
    Pediatrics; 1996 Apr; 97(4):524-8. PubMed ID: 8632940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A universal array-based multiplexed test for cystic fibrosis carrier screening.
    Amos JA; Bridge-Cook P; Ponek V; Jarvis MR
    Expert Rev Mol Diagn; 2006 Jan; 6(1):15-22. PubMed ID: 16359263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interference of P1290 P polymorphism (4002 A--> G) in molecular diagnosis of mucoviscidosis using the cystic fibrosis assay: an example of a diagnostic trap].
    Bienvenu T; Bousquet S; Souville I; Beldjord C
    Ann Biol Clin (Paris); 1999; 57(6):741-2. PubMed ID: 10572229
    [No Abstract]   [Full Text] [Related]  

  • 12. [Functional characterization of naturally occurring CFTR mutants: interest for cystic fibrosis].
    Romey MC
    Ann Biol Clin (Paris); 2006; 64(5):429-37. PubMed ID: 17040873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-performance pyrolysis-gas chromatography: potential for differentiating cystic fibrosis cells.
    Reiner EJ; Moran TF
    J Chromatogr; 1980 Dec; 221(2):371-6. PubMed ID: 7217305
    [No Abstract]   [Full Text] [Related]  

  • 14. Glucose homeostasis and genotype-phenotype interplay in cystic fibrosis patients with CFTR gene deltaF508 mutation.
    Preumont V; Hermans MP; Lebecque P; Buysschaert M
    Diabetes Care; 2007 May; 30(5):1187-92. PubMed ID: 17337503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of IKK and ERK pathways in intrinsic inflammation of cystic fibrosis airways.
    Verhaeghe C; Remouchamps C; Hennuy B; Vanderplasschen A; Chariot A; Tabruyn SP; Oury C; Bours V
    Biochem Pharmacol; 2007 Jun; 73(12):1982-94. PubMed ID: 17466952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transport of labelled compounds in control and cystic-fibrosis cells in vitro.
    Benke PJ; Pitot HC; Erbstoeszer M
    Lancet; 1972 Jan; 1(7743):182-4. PubMed ID: 4109552
    [No Abstract]   [Full Text] [Related]  

  • 17. Nucleic acids methylation of synchronized BHK 21 HS 5 fibroblasts during the mitotic phase.
    Bugler B; Bertaux O; Valencia R
    J Cell Physiol; 1980 Apr; 103(1):149-57. PubMed ID: 6159363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal beta-glucuronidase activity in cystic fibrosis.
    Marchi AG; Marchi MA; Mastella G; Nordio S
    Helv Paediatr Acta; 1973 Nov; 28(5):427-35. PubMed ID: 4773224
    [No Abstract]   [Full Text] [Related]  

  • 19. Cystic fibrosis: demonstration of an abnormality in mucopolysaccharides in cultured lymphoid lines.
    Danes BS; Backofen JE; Rottell BK
    Biochem Genet; 1974 Nov; 12(5):359-66. PubMed ID: 4282246
    [No Abstract]   [Full Text] [Related]  

  • 20. Geographic distribution of cystic fibrosis transmembrane regulator gene mutations in Saudi Arabia.
    Banjar H
    East Mediterr Health J; 1999 Nov; 5(6):1230-5. PubMed ID: 11924117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.